The US Food and Drug Administration’s ‘Purple Book’ biologics counterpart to its ‘Orange Book’ for small-molecule drugs has been overhauled by the agency to turn it into a searchable database of biologics information.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?